This is a positive message from G. Vanden Bossche (can you imagine?!) to all those who were jabbed but now want their innate immune system to revert to ‘virgin’ status. Now is the time to do it! Why and how?
Omicron will soon dominate the scene. As it is poorly (or not at all) recognized by S(pike)-directed antibodies (Abs) that are either induced by the current C-19 vaccines (containing Wuhan’s S protein) or by short-lived anti-S Abs of low affinity that result from previous asymptomatic/ mild infection with the Delta variant, your valuable innate Abs capable of handling ALL SARS-CoV-2 variants will now be set free! [note 1]
To qualify for this offer, you only have to do the following:
Q: Can Omicron still make you ill despite a restored innate immune status?
A: Yes. However, one must realize that for healthy vaccinees who don’t continue (updated) booster shots, the probability of contracting severe diseases is likely remote. However, as Omicron is highly infectious, both vaccinees and unvaccinated people could easily become re-exposed to Omicron while still sitting on anti-Omicron S Abs of low affinity (as a result of a recent mild/ asymptomatic infection).
This may cause mild to moderate disease in a substantial part of the population, especially in vaccinees, as training of their innate Abs had stalled as a result of previous immune suppression by vaccinal anti-Wuhan S Abs. However, I expect this phase to be of short duration as a steep incline in the viral infection rate (due to high level of Omicron’s infectiousness) will likely be followed by a steep decline (due to massive sterilizing immunity provided by a large cohort of asymptomatically/ mildly infected individuals).
In addition, the more people refrain from getting jabbed with an updated anti-Omicron vaccine, the more readily we (Wuhan S-vaccinated and unvaccinated together!) will diminish the infectious pressure in the population and, therefore, mitigate disease symptoms and achieve herd immunity (thanks to sterilizing immunity conferred by a fully functional innate immune system). This will largely prevent healthy individuals from contracting the disease and even protect the most vulnerable who lack full-fledged innate immunity because of underlying conditions.
[note 1]: For those who want to understand how this fits into the evolutionary landscape of a virus that has been put under widespread high immune pressure (due to mass vaccination), please consult: https://www.voiceforscienceandsolidarity.org/scientific-blog/will-mass-vaccination-against-omicron-give-the-final-blow as well as https://www.voiceforscienceandsolidarity.org/scientific-blog/omicron-the-calm-before-the-tsunami
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.